This message was sent to ##Email##
|
| February 12, 2020 |
| |  | | |
|
| |
CAP TODAY
The authors of an article published in the Journal of the American Society of Cytopathology participated in a public hearing at the Food and Drug Administration in January 2018. The hearing advised the FDA about what research would be required to demonstrate the safety and efficacy of a self-collected Papanicolaou test device. In the article, Staats, et al., review the literature on self-collected Pap tests.
READ MORE
ASCT
We are happy to announce that the ASCT Foundation will once again hold a silent auction during this year’s ASCT Annual Conference! Monies raised will go directly toward helping the ASCT Foundation fulfill its mission to support and enhance many of the programs provided by ASCT. In addition to educational programs and awards, the foundation supports student attendance at the ASCT Annual Conference by covering the registration fee for student members who register by the early deadline. In addition, the foundation supports the Rookie of the Year Award, a scholarship that will cover the cost of travel and registration for a recent graduate.
The foundation is currently seeking donations of items for the auction. Previous donations have included original artwork, hand-made craft items, gift cards, and cytology textbooks. If you would like to donate contact Liza DiFilippo at lizadifilippo@gmail.com.
 |
|
The F-50 Non-Gyn Slide Processor has a liquid-based cytology system that features more cells per slide, and doesn’t need duplicate preps. The dual filtration disposable filters remove non-diagnostic material to optimize cell presentation. Cells of interest are transferred to the slide in a homogenous thin-layer cell deposit. Throughput: 50 samples/hr.
|
|
| Date |
Event |
Location |
More information |
February 26, 2020 |
Employee Engagement in the Laboratory: Empowering a Positive Workforce
|
Your PC |
Jodie M. Woodside MS, CT (ASCP)CM
Rutland Regional Medical Center
Rutland, Vermont
Details |
March 18, 2020 |
Aspiration Cytology of Neck Cysts in Adults: Morphologic Features and Ancillary Testing Strategies
|
Your PC |
Dr. Christopher Griffith
Cleveland Clinic
Cleveland, Ohio
Details |
March 18, 2020 |
Aspiration Cytology of Neck Cysts in Adults: Morphologic Features and Ancillary Testing Strategies
|
Your PC |
Dr. Christopher Griffith
Cleveland Clinic
Cleveland, Ohio
Details |
April 22, 2020 |
Molecular Cytopathology in an Era of Precision Medicine: Doing More with Less
|
Your PC |
Dr. Sinchita Roy-Chowdhuri
MD Anderson Medical Center
Houston, Texas
Details |
June 2020 |
Soft Tissue and Bone FNA
|
Your PC |
Dr. Benjamin Witt
Associate Professor of Anatomic Pathology
University of Utah/ARUP Laboratories
Salt Lake City, Utah
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC) Cell Blocks Basics Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
Document Control for Cytopathology Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench
|
Your PC |
Details |
CAP TODAY
The Food and Drug Administration approved in 2001 the first testing modality for the detection of HPV in gynecological cytological specimens. To date, there are now five FDA-approved testing modalities, and molecular testing for high-risk HPV has become commonplace. Numerous studies have shown that high-risk HPV testing is more sensitive in detecting high-grade squamous intraepithelial lesion/cervical intraepithelial neoplasia grade two and above (HSIL/CIN2+) than cytology alone, but that cytology is more specific.
READ MORE
The Guardian
More than 74 million cervical cancer cases and 62 million deaths could be averted in the next 100 years if 78 of the world's poorest countries rapidly deploy HPV vaccinations, cervical screening and cancer treatment, two new studies have projected. The predictive modeling was published in Lancet by Université Laval, Harvard University and Cancer Council New South Wales working with the World Health Organization. All three teams independently developed their models based on the biological understanding of cervical cancer, and multiple data sources from multiple countries located in east Asia and Pacific, Europe and central Asia, Latin America and Caribbean, the Middle East and North Africa, South Asia and sub-Saharan Africa.
READ MORE
Physician's Weekly
Given the poor survival rates for women with advanced cervical cancer, new treatment regimens are needed. Although today's standard of care for advanced cervical cancer is chemotherapy in combination with external beam radiation therapy (EBRT), a growing body of evidence demonstrates that brachytherapy administered after chemo/EBRT improves overall survival.
READ MORE
Cancer Therapy Advisor
Patients diagnosed with human papillomavirus (HPV)-negative oropharynx head and neck cancer had higher rates of cancer-specific mortality, all-cause mortality, second-cancer mortality, and competing-cause mortality compared with patients with HPV-positive disease, according to a new study. "To the best of our knowledge, this is the first population-based study to assess causes of early mortality stratified by HPV status among patients with OPC [oropharynx cancer] in the United States," the researchers wrote. "These findings provide data to individualize risk profiles for specific early mortality events and survivorship screening for second malignancies."
READ MORE
Memorial Sloan Kettering Cancer Center
Human papillomavirus (HPV) causes several types of cancer, including cervical, anal, and head and neck cancers. People with these tumors are more easily cured with radiation and chemotherapy than people with tumors not caused by HPV. Scientists at Memorial Sloan Kettering now think they understand why. "We've known that HPV-associated cancers respond much better to radiation therapy, but it hasn't been clear why that is," says Daniel Higginson, a physician-scientist at MSK. "Our research shows that it's likely because the virus alters the cells' normal DNA repair machinery."
READ MORE
|
|
|
|
|
| |
Medical Xpress
In addition to changes in the administration of some vaccines, the 2020 schedule includes new instructions for shared clinical decision-making for several vaccines. First, the HPV vaccine is recommended for some patients aged 27 through 45 who are not adequately vaccinated. Clinicians should consider discussing HPV vaccination with those who are most likely to benefit from it based on a detailed list of considerations.
READ MORE
World Health Organization
The World Health Organization (WHO) recently spelled out the need to step up cancer services in low and middle-income countries. WHO warns that, if current trends continue, the world will see a 60% increase in cancer cases over the next two decades. The greatest increase (an estimated 81%) in new cases will occur in low- and middle-income countries, where survival rates are currently lowest.
READ MORE
News-Medical.net
Higher levels of mercury in the blood were linked with a higher prevalence of non-melanoma skin cancer, the most common human malignancy, in a study published in the British Journal of Dermatology.
READ MORE
Physics World
Tumor hypoxia, defined as low levels of oxygen partial pressure (pO2), can cause resistance to radiotherapy. The ability to characterize tumor hypoxia could help to optimize radiation treatments. But there’s currently a lack of methods to monitor tumor oxygenation noninvasively or without averaging across the entire lesion.
READ MORE
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
